The effect of combination treatment with aliskiren and blockers of the renin-angiotensin system on hyperkalaemia and acute kidney injury: systematic review and meta-analysis
about
Targeting NADPH oxidases in vascular pharmacologyHemodynamic and hormonal changes to dual renin-angiotensin system inhibition in experimental hypertension.Treatment of hypertension in obese patients.Aliskiren: review of efficacy and safety data with focus on past and recent clinical trials.Aliskiren, the first direct renin inhibitor: assessing a role in pediatric hypertension and kidney diseases.Aliskiren ameliorates pressure overload-induced heart hypertrophy and fibrosis in miceAliskiren - an alternative to angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in the therapy of arterial hypertensionBlood pressure lowering efficacy of renin inhibitors for primary hypertension.Active vitamin D treatment for reduction of residual proteinuria: a systematic review.Effect of aliskiren on cardiovascular outcomes in patients with prehypertension: a meta-analysis of randomized controlled trials.Acute kidney injury: an acceptable risk of treatment with renin-angiotensin system blockade in primary care?Renin inhibitors in diabetes and hypertension: an update.Efficacy of aliskiren, compared with angiotensin II blockade, in slowing the progression of diabetic nephropathy in db/db mice: should the combination therapy be a focus?Renin-Angiotensin-Aldosterone System Blockade in Diabetic Nephropathy. Present Evidences.Normal 25-Hydroxyvitamin D Levels Are Associated with Less Proteinuria and Attenuate Renal Failure Progression in Children with CKD.Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trialsAn additive effect of eplerenone to ACE inhibitor on slowing the progression of diabetic nephropathy in the db/db mice.Risk of acute kidney injury associated with the use of fluoroquinolones.Dual renin-angiotensin system inhibition for prevention of renal and cardiovascular events: do the latest trials challenge existing evidence?Therapeutic approaches to slowing the progression of diabetic nephropathy - is less best?Renin inhibitors and cardiovascular and renal protection: an endless quest?Relationship between five GLUT1 gene single nucleotide polymorphisms and diabetic nephropathy: a systematic review and meta-analysis.Renin inhibition in the treatment of diabetic kidney disease.Is there benefit in dual renin-angiotensin-aldosterone system blockade? No, yes and maybe: a guide for the perplexed.Chronic kidney disease: a new look at pathogenetic mechanisms and treatment options.Direct renin inhibition: extricating facts from façades.Plasma renin and cardiovascular risk: what is the evidence for an association?Renin-angiotensin system blocking drugs.Drug-induced hyperkalemia.Oxidative stress and early atherosclerosis: novel antioxidant treatment.Treatment of hypertension in children with chronic kidney disease.Drug therapy of apparent treatment-resistant hypertension: focus on mineralocorticoid receptor antagonists.Combination therapy in chronic kidney disease?Role of the Renin-Angiotensin-Aldosterone System and Its Pharmacological Inhibitors in Cardiovascular Diseases: Complex and Critical Issues.Exploring the myths of morphine in cancer: views of the general practice population.Efficiency and specificity of RAAS inhibitors in cardiovascular diseases: how to achieve better end-organ protection?Evaluation of the Potential for Drug Interactions With Patiromer in Healthy Volunteers.Kinetics of the inhibition of renin and angiotensin I-converting enzyme by cod (Gadus morhua) protein hydrolysates and their antihypertensive effects in spontaneously hypertensive rats.Effects of aliskiren on mortality, cardiovascular outcomes and adverse events in patients with diabetes and cardiovascular disease or risk: A systematic review and meta-analysis of 13,395 patients.Association between glucose transporter 1 rs841853 polymorphism and type 2 diabetes mellitus risk may be population specific (1rs8418532).
P2860
Q26863500-A58C4AD2-C43D-482C-973D-E83A0BE00284Q30415031-A5E6C282-CA59-4E4F-BF12-EFE2F4C0F76AQ30429298-3BF9DD43-CB0B-407C-A751-5E74DB0188B8Q30664624-A05BE77F-948B-404E-98D3-894C3584D32BQ33756874-06761DF3-E2F2-498C-8DC8-343DECF9D228Q34017983-92642DD7-C21A-4860-BFC9-C6307AD46CF2Q34247173-792D4FAA-EA6F-4D9E-92EA-6BB27E44E0C7Q34681386-E33AEE28-F73C-407B-AFE3-901AC570B9EEQ34912750-C6E694EC-9C26-4A2A-9D60-3C9137972998Q35408572-1C4C9668-E269-4C07-8B2C-333497772EDAQ35552840-92498018-7AC3-4CCA-9663-D2433A35CA09Q35728190-51A462BB-2049-4E62-A966-7480A2DB1DA9Q35826450-8F604D01-572E-42BA-9E9B-82EE8D1C2150Q36329456-718E3E85-FCF5-437D-B164-F0F0B814994DQ36417881-83500C57-4815-4BE2-88C8-987EE35D888EQ36567554-4C6324A2-A022-445D-A918-9DDEFAC95483Q36878533-75240A66-8E6B-4F6A-84CE-F995D8BE8F63Q37001458-62860DCE-0904-4260-85E6-D9219FD9ADDAQ37053287-7DCF7EB5-263A-41AC-809F-2833D77F9ACCQ37449207-AB7A5DAE-71BB-493E-A885-E4AF452E003DQ37990796-AF4CD887-82F8-4844-BC45-0BE835C76466Q38019453-25903A75-DA22-431A-9ACB-D2832A46524CQ38075571-ECD93075-398A-48DE-8DDB-A116D4ABDEA2Q38076689-56191F31-E8F3-4741-BA76-0D738F20C9ECQ38087529-E592F210-C668-48DE-9B09-18A9BA9AE5A4Q38088975-CC192FFF-703C-4D5F-9CA3-7946862C19C1Q38103400-EB6B9516-9888-43E1-B3CC-896EFE90E729Q38137851-A1754F80-4E96-4FBB-8F12-08EFB51CEA7AQ38232308-49A2CA04-9357-447F-84C2-1CABF65A8F1EQ38269619-7D89C132-22CA-4703-B620-55C563E05FE9Q38272557-9799A70E-AD18-4186-A7F0-0A677C70B568Q38383249-C5A0AF7F-B1BF-4681-B3D8-BFAA954C68B7Q38425078-F5225BBC-8708-4BB3-A6EB-FCC81D6B7490Q38592420-CD18ED93-A9CA-4F71-A8A2-25992DF36994Q39142821-4BFCB342-9F2F-4917-823C-AFE0B3BA3A47Q39416346-668F54D5-7914-4A32-95DC-A349E05A4CA2Q41380691-DC46056F-4C80-4B89-9026-6E9D5241C68AQ41511792-590ECC29-2CEF-4113-AB6E-6B37AA7B4A7AQ41712920-2E6E1983-A1AA-4126-A318-FFFD5778A928Q43851298-78B138CC-D9ED-4540-80E6-04D055E73F3E
P2860
The effect of combination treatment with aliskiren and blockers of the renin-angiotensin system on hyperkalaemia and acute kidney injury: systematic review and meta-analysis
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The effect of combination trea ...... matic review and meta-analysis
@ast
The effect of combination trea ...... matic review and meta-analysis
@en
The effect of combination trea ...... matic review and meta-analysis
@nl
type
label
The effect of combination trea ...... matic review and meta-analysis
@ast
The effect of combination trea ...... matic review and meta-analysis
@en
The effect of combination trea ...... matic review and meta-analysis
@nl
prefLabel
The effect of combination trea ...... matic review and meta-analysis
@ast
The effect of combination trea ...... matic review and meta-analysis
@en
The effect of combination trea ...... matic review and meta-analysis
@nl
P2093
P2860
P31
P921
P356
P1433
P1476
The effect of combination trea ...... matic review and meta-analysis
@en
P2093
Cameron Gilbert
David Juurlink
Joseph Beyene
Prakesh S Shah
P2860
P356
10.1136/BMJ.E42
P407
P50
P5008
P577
2012-01-09T00:00:00Z